Department of Anaesthesia and Critical Care, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Eur J Anaesthesiol. 2012 Dec;29(12):561-9. doi: 10.1097/EJA.0b013e3283560aea.
Volatile anaesthetics may have direct cardioprotective properties due to effects similar to ischaemic preconditioning and postconditioning. Clinical results in cardiac surgery patients are controversial and may be related to the timing of administration of anaesthetics intraoperatively.
We hypothesised that the cardioprotective effect of sevoflurane in coronary bypass graft surgical patients would be greater if administration during anaesthesia continued in the ICU for at least 4 h postoperatively until weaning from mechanical ventilation.
Double-blind, double-dummy, prospective, randomised and controlled clinical trial.
In a single centre between June 2006 and June 2007.
Seventy-five adult patients were assigned randomly to receive anaesthesia and postoperative sedation either with propofol (control, n = 37) or sevoflurane (n = 36).
Myocardial biomarkers were measured before surgery, at the time of admission to the intensive care unit and at 6, 24, 48 and 72 h. The need for inotropic support, and lengths of stay in the intensive care unit and hospital were also recorded.
Elevation of myocardial biomarkers was the primary endpoint. The secondary endpoints were haemodynamic events and lengths of stay in the intensive care unit and hospital.
Necrosis biomarkers increased significantly in the postoperative period in both groups with no significant differences at any time. Inotropic support was needed in 72.7 and 54.3% of patients in the propofol and sevoflurane groups, respectively (P = 0.086). There were no significant differences in haemodynamic variables, incidence of arrhythmias, myocardial ischaemia or and lengths of stay in the ICU and hospital between the two groups.
In patients undergoing coronary bypass graft surgery, continuous administration of sevoflurane as a sedative in the ICU for at least 4 h postoperatively did not yield significant improvements in the extent and time course of myocardial damage biomarkers compared to propofol.
挥发性麻醉剂可能具有直接的心脏保护特性,这是由于其作用类似于缺血预处理和后处理。心脏外科患者的临床结果存在争议,这可能与麻醉剂术中给药的时间有关。
我们假设如果在冠状动脉旁路移植术患者的麻醉期间,至少在术后 ICU 中继续给予七氟醚,持续 4 小时以上,直到从机械通气中脱机,那么七氟醚的心脏保护作用将更大。
双盲、双模拟、前瞻性、随机对照临床试验。
2006 年 6 月至 2007 年 6 月在一个中心进行。
75 名成年患者被随机分配接受异丙酚(对照组,n = 37)或七氟醚(n = 36)麻醉和术后镇静。
在手术前、入住重症监护病房时以及 6、24、48 和 72 小时时测量心肌生物标志物。还记录了需要正性肌力支持以及在重症监护病房和医院的停留时间。
心肌生物标志物的升高是主要终点。次要终点是血流动力学事件以及在重症监护病房和医院的停留时间。
两组患者在术后期间均显著升高,且在任何时间均无显著差异。分别有 72.7%和 54.3%的患者需要异丙酚和七氟醚支持(P = 0.086)。两组之间的血流动力学变量、心律失常、心肌缺血或和在 ICU 和医院的停留时间均无显著差异。
在接受冠状动脉旁路移植术的患者中,与异丙酚相比,在术后 ICU 中至少连续 4 小时给予七氟醚作为镇静剂,并未显著改善心肌损伤生物标志物的程度和时间进程。